Androgenetic Alopecia
Information
- Disease name
- Androgenetic Alopecia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT06066827 | Active, not recruiting | N/A | Hair Regeneration in Androgenetic Alopecia | August 14, 2023 | November 30, 2023 |
NCT06043349 | Active, not recruiting | Phase 4 | Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia | June 1, 2023 | September 30, 2023 |
NCT06126965 | Active, not recruiting | Phase 3 | Phase III Study of KX-826 With Adult Male Patients With AGA | December 29, 2021 | May 31, 2024 |
NCT05456087 | Active, not recruiting | Phase 2 | Use of Botulinum Toxin in the Treatment of Androgenic Alopecia | August 12, 2022 | December 2024 |
NCT00947219 | Completed | N/A | Treatment of Androgenic Alopecia in Males | July 2009 | August 2010 |
NCT00947505 | Completed | N/A | Treatment of Androgenetic Alopecia in Males | August 2009 | August 2010 |
NCT00958750 | Completed | Phase 3 | Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia | June 2008 | June 2009 |
NCT00981461 | Completed | N/A | Treatment of Androgenetic Alopecia in Females, 9 Beam | October 2009 | October 2010 |
NCT01016964 | Completed | N/A | Treatment of Androgenetic Alopecia in Females, 12 Beam | January 2010 | March 2011 |
NCT01052870 | Completed | Phase 1 | Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic Alopecia | December 2008 | December 2009 |
NCT01226459 | Completed | Phase 3 | Clinical Trial in Females for Female Pattern Hair Loss | September 2010 | August 2011 |
NCT01231607 | Completed | Phase 3 | Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia | October 28, 2010 | February 28, 2012 |
NCT01286649 | Completed | Phase 1/Phase 2 | Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia | December 2010 | February 23, 2017 |
NCT01309191 | Completed | N/A | Microarray Analysis of Scalp Biopsies After Minoxidil Treatment | April 2011 | April 2012 |
NCT01319370 | Completed | Phase 2 | Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia | November 2010 | March 2013 |
NCT01391156 | Completed | Phase 3 | Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss | March 2011 | March 2012 |
NCT01437163 | Completed | N/A | Treatment of Androgenetic Alopecia in Males and Females | September 2011 | August 2013 |
NCT01451021 | Completed | Phase 2 | A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss | October 2008 | |
NCT01451047 | Completed | Phase 2 | A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012) | July 2009 | |
NCT01451073 | Completed | Phase 2 | A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013) | January 2009 | |
NCT01451099 | Completed | Phase 2 | A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss | June 2009 | |
NCT01451112 | Completed | Phase 2 | A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899) | August 2009 | |
NCT01451125 | Completed | Phase 2 | A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512) | May 2010 | |
NCT01451138 | Completed | Phase 2 | A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541) | November 2010 | |
NCT01451151 | Completed | Phase 2 | A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542) | December 2010 | |
NCT01451177 | Completed | Phase 2 | A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669) | May 2010 | |
NCT00151515 | Completed | Phase 3 | A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss | October 2003 | July 2004 |
NCT01548066 | Completed | Phase 2 | The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss | September 2011 | June 2012 |
NCT01451190 | Completed | Phase 2 | A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995) | July 2011 | |
NCT00396175 | Completed | Phase 3 | Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111) | March 1998 | |
NCT00418730 | Completed | Phase 2 | Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss | January 2007 | April 2008 |
NCT00926211 | Completed | N/A | Computer-Assisted Versus Manual Hair Harvest Comparative Study | June 2009 | September 2010 |
NCT01669746 | Completed | Phase 2 | A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931) | June 2012 | |
NCT01701271 | Completed | N/A | Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females | February 2001 | June 2001 |
NCT01967277 | Completed | N/A | A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy | March 2014 | September 2014 |
NCT02067260 | Completed | N/A | A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males | ||
NCT02150187 | Completed | Phase 2 | Efficacy of Nutrition Supplement for Treatment of Men With Hair Loss | May 2014 | May 2015 |
NCT02170662 | Completed | Phase 2 | Topical Bimatoprost Effect on Androgen Dependent Hair Follicles | November 2009 | May 2011 |
NCT02198261 | Completed | Minoxidil Response Testing in Males With Androgenetic Alopecia | July 2014 | October 2018 | |
NCT02275351 | Completed | Phase 2 | A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA) | November 2014 | November 2015 |
NCT02279823 | Completed | Phase 2 | A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia | October 2014 | May 2016 |
NCT02280603 | Completed | Phase 1/Phase 2 | Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application | January 2014 | December 2014 |
NCT02494297 | Completed | DUS on the Prescribing Indications for CPA/EE in 5 European Countries | March 6, 2015 | October 31, 2016 | |
NCT02503137 | Completed | Phase 2 | A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing | August 2015 | April 2016 |
NCT02591355 | Completed | N/A | Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment | September 6, 2017 | November 18, 2019 |
NCT02626780 | Completed | N/A | Adipose-derived SVF for Treatment of Alopecia | July 20, 2016 | January 22, 2017 |
NCT02729415 | Completed | N/A | Point-of-Care Adipose-derived Cells for Hair Growth | October 2016 | January 31, 2019 |
NCT02791243 | Completed | Phase 1 | Photosensitization Study in Androgenetic Alopecia | May 9, 2016 | June 27, 2016 |
NCT02848300 | Completed | Phase 1 | Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia | July 2016 | October 2016 |
NCT03376581 | Completed | Early Phase 1 | The Utility of Platelet Rich Plasma in Hair Loss | November 28, 2017 | February 20, 2019 |
NCT03394235 | Completed | N/A | Optimizing Parameters for Long-pulsed Nd:YAG Laser for Reducing Hair Shaft Diameter | February 2, 2018 | January 16, 2019 |
NCT03495817 | Completed | Phase 2 | A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution | March 22, 2018 | October 30, 2019 |
NCT03689452 | Completed | N/A | The Effect of Platelet Rich Plasma on Non-scarring Alopecia | October 1, 2018 | June 3, 2019 |
NCT03694067 | Completed | Androgenetic Alopecia and the JAK-STAT Pathway | October 15, 2018 | December 1, 2019 | |
NCT03742518 | Completed | Phase 2/Phase 3 | A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia | November 1, 2018 | December 31, 2020 |
NCT03753113 | Completed | Phase 3 | Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5% | November 28, 2018 | September 2, 2019 |
NCT04019795 | Completed | Phase 3 | Modulated Light Therapy in Participants With Pattern Hair Loss | January 5, 2017 | May 25, 2019 |
NCT04214808 | Completed | Phase 1 | To Evaluate the Pharmacokinetics and Safety of AD-208 | January 3, 2020 | May 4, 2020 |
NCT04379752 | Completed | N/A | Cold Plasma to Treat Hair Loss | July 1, 2020 | September 15, 2021 |
NCT04446429 | Completed | N/A | Anti-Androgen Treatment for COVID-19 | October 21, 2020 | January 21, 2021 |
NCT04450589 | Completed | N/A | A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair Loss | April 11, 2018 | October 23, 2018 |
NCT04450602 | Completed | N/A | A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss | April 3, 2018 | October 23, 2018 |
NCT04481412 | Completed | Phase 2/Phase 3 | Topical Cetirizine in Androgenetic Alopecia in Females | July 25, 2020 | November 30, 2021 |
NCT04502901 | Completed | Phase 1 | the Safety, Tolerability and PK of KX-826 in Healthy Males With Alopecia Following Topical Multiple Dose Ascending | January 14, 2020 | January 15, 2021 |
NCT04774874 | Completed | Phase 2 | A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers | June 24, 2020 | January 29, 2021 |
NCT04825561 | Completed | Phase 3 | A Study to Evaluate the Efficacy and Safety of AD-208 | June 9, 2021 | June 1, 2023 |
NCT04898166 | Completed | Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19). | December 1, 2020 | March 31, 2021 | |
NCT04945226 | Completed | Phase 1/Phase 2 | A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001 | September 21, 2021 | February 8, 2022 |
NCT04984707 | Completed | Phase 1 | Safety, Tolerability and Pharmacokinetics of KX826 in Healthy Male Subjects With Androgenetic Alopecia Following Topical Single Ascending Dose Administration | January 28, 2019 | October 24, 2019 |
NCT05324293 | Completed | Phase 1 | To Evaluate the Safety, Tolerability and Efficacy in Male and Female With AGA Treated With HMI-115 Over a 24-week Treatment Period | May 11, 2022 | September 11, 2023 |
NCT05428449 | Completed | Phase 1 | Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029 | February 10, 2022 | April 6, 2023 |
NCT05636904 | Completed | Phase 1/Phase 2 | Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men | December 5, 2022 | March 28, 2024 |
NCT05989165 | Completed | Phase 3 | Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men | June 1, 2023 | September 15, 2023 |
NCT06149221 | Completed | N/A | Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss | September 1, 2023 | April 12, 2024 |
NCT05864885 | Not yet recruiting | Phase 1 | Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia | June 9, 2023 | July 17, 2023 |
NCT05888922 | Not yet recruiting | Phase 3 | Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia | June 2024 | September 2025 |
NCT06218394 | Recruiting | N/A | Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia | December 14, 2023 | December 31, 2024 |
NCT05365360 | Recruiting | N/A | Sham LaserCap vs. LaserCap SD vs. LaserCap HD+ | June 1, 2022 | May 2025 |
NCT06393452 | Recruiting | Phase 2 | Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA | June 5, 2024 | February 2025 |
NCT06118866 | Recruiting | Phase 2 | A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia | September 11, 2023 | December 2024 |
NCT05970809 | Recruiting | N/A | Assessing the Safety and Efficacy of a Novel Microneedling and Laser Device for Male Pattern Hair Loss | June 1, 2023 | September 1, 2024 |
NCT06218498 | Recruiting | N/A | Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Er Laser for the Treatment of Androgenetic Alopecia | November 24, 2023 | December 31, 2024 |
NCT04594018 | Recruiting | Phase 3 | Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia | February 2, 2023 | September 2025 |
NCT05677438 | Recruiting | Phase 2 | A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia | December 20, 2022 | April 30, 2024 |
NCT06239207 | Recruiting | Phase 2 | Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia | September 21, 2023 | July 21, 2024 |
NCT05990400 | Recruiting | Phase 2/Phase 3 | Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia | May 1, 2023 | December 30, 2023 |
NCT05460611 | Recruiting | N/A | 1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia | December 7, 2023 | December 2025 |
NCT02548689 | Terminated | PAI-1 Expression in Non-scarring Hair Loss | July 2015 | June 2021 | |
NCT02154503 | Unknown status | Phase 1 | Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia | April 2014 | March 2017 |
NCT04558242 | Unknown status | N/A | Low Level Light Device as a Primary Therapy for Androgenetic Alopecia | August 1, 2020 | August 1, 2021 |
NCT02393040 | Unknown status | N/A | Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia | January 2014 | November 2015 |
NCT05348343 | Unknown status | Phase 1/Phase 2 | Activated PRP for Treatment of Androgenetic Alopecia | May 17, 2022 | March 31, 2023 |
NCT01686295 | Unknown status | N/A | 24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness | July 2012 | May 2013 |
NCT04293822 | Unknown status | Phase 4 | Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia | June 2020 | November 2021 |
NCT01643629 | Unknown status | Phase 1/Phase 2 | A Study to Determine the Safety and Efficacy of Autologous Human Platelet Lysate for Treatment of Androgenetic Alopecia | January 2012 | November 2012 |
NCT04191005 | Unknown status | Efficacy of Platelet-Rich Plasma Therapy for Androgenetic Alopecia: A Systematic Review and Meta-analysis | January 7, 2020 | January 30, 2020 | |
NCT04209803 | Unknown status | Phase 4 | N-Acetyl-Cysteine for Treatment of AGA in Men | December 1, 2018 | October 2020 |
NCT01655602 | Unknown status | Phase 1 | Split Wound Comparison of Trichophytic Closure Techniques for Donor Site in Hair Transplantation | July 2012 | May 2013 |
NCT02074943 | Unknown status | N/A | Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia | April 2014 | December 2015 |
NCT02528552 | Unknown status | Phase 2 | Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO | August 2015 | December 2016 |
NCT01644422 | Unknown status | Phase 1/Phase 2 | Study To Determine Safety & Efficacy Of Autologous Human Platelet Lysate in Androgenetic Alopecia After Hair Transplant | January 2012 | November 2012 |
NCT01501617 | Unknown status | Phase 1/Phase 2 | Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia | December 2011 | December 2012 |
NCT04842383 | Unknown status | Early Phase 1 | Androgenetic Alopecia Treatment Using Varin and Cannabidiol Rich Topical Hemp Oil: A Case Series | April 5, 2021 | October 4, 2021 |
NCT01227031 | Unknown status | Pharmacogenomic Study of Androgenetic Alopecia | October 2010 | July 2011 | |
NCT01885676 | Unknown status | N/A | Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia | ||
NCT02999737 | Unknown status | Phase 4 | Comparing Different Platelet Rich Plasma (PRP) Treatment Regimens for Management of Androgenic Alopecia | November 2016 | August 2017 |
NCT00471510 | Unknown status | Phase 2 | Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss | May 2007 | |
NCT03388840 | Unknown status | Phase 4 | Adipose Derived Stem Cells Versus Platelet Rich Plasma on Follicular Unit Extraction | January 15, 2018 | March 2021 |
NCT05129800 | Unknown status | Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study | December 2021 | February 2022 | |
NCT02486848 | Withdrawn | N/A | Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil | June 2016 | December 2016 |
NCT04882969 | Withdrawn | N/A | Thulium Laser and KeraFactor for the Treatment of Androgenetic Alopecia | September 1, 2021 | December 31, 2024 |
NCT04379583 | Withdrawn | HairDx Analytical Validation Study | June 15, 2020 | December 6, 2021 | |
NCT03852992 | Withdrawn | Phase 2 | Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia | September 30, 2022 | July 1, 2023 |
NCT04368897 | Withdrawn | In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity | May 1, 2020 | December 1, 2022 | |
NCT05129254 | Withdrawn | N/A | Thulium Laser and Topical Platelet Rich Plasma (PRP) vs. PRP Injection for the Treatment of Male Androgenetic Alopecia | July 1, 2022 | December 31, 2025 |
NCT03048461 | Withdrawn | Phase 2 | The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia | June 2019 | December 2020 |